BAC vs NVAX Stock Comparison

Compare BAC vs NVAX on performance, valuation, growth, fundamentals, momentum and risk; the current AIQ evidence does not show a clear headline leader.

Market data as of Nov 15, 2026 market close
BAC
Financial Services
vs
NVAX
Healthcare
BAC
Bank of America Corporation
Price
$51.02
Day move
+1.01%
AIQ Score
58/100
Best edge
Risk Resilience
Sector
Financial Services
NVAX
Novavax, Inc.
Price
$8.53
Day move
-2.68%
AIQ Score
-/100
Best edge
Momentum
Sector
Healthcare

What is the main difference between BAC and NVAX?

BAC and NVAX are close on the current AIQ evidence, so the better fit depends more on objective, risk tolerance and valuation preference than on a single headline score.

AlgovestIQ AIQ Comparison

Bank of America Corporation vs Novavax, Inc.

Data as of Nov 15, 2026· market close· Cross-sector · Financial Services vs Healthcare· Coverage 61/66 fields· High confidence
AIQ VerdictFragile

BAC and NVAX are effectively level

BAC and NVAX are effectively level on the AIQ Score; the factor table below shows where each one holds its advantage.

Evidence agreement: 0 of 4
BAC

Bank of America Corporation

AIQ Score
58/100
AIQ Edge Score
6/10
NVAX

Novavax, Inc.

AIQ Score
—/100
AIQ Edge Score
—

The Algovestiq AIQ Score does not currently separate BAC and NVAX as of Nov 15, 2026. Both names are scored on the same 0–100 scale across Quality, Value, Momentum and Risk Resilience, and the factor table below shows where each one holds its advantage.

Compare Bank of America Corporation and Novavax, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

BAC
+24.0%
NVAX
-95.4%

Total return comparison

Growth of $10,000, distributions reinvested

BAC $12,399 · NVAX $463

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare BAC and NVAX against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

BAC advantage
0
NVAX advantage
  • Risk Resilience83 vs 38
    BAC +45
  • Momentum37 vs 77
    NVAX +40
  • Quality64 vs 62
    Even

Neither name separates cleanly on the covered dimensions.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

BAC0 AIQ

No factor moved materially.

New signals

  • OBV Bullish Divergence — bullish, volume, medium horizon (-0.4%)
NVAX

Largest factor move: Momentum +3

No signal started or stopped since the prior session; its 6 active signals are unchanged.

Deeper signal detail for each name lives on its own signals page — BAC and NVAX both carry a full feed there.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

Even

Neither separates on the overall score.

Growth

NVAX

NVAX on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

NVAX

NVAX on the Momentum factor, by 40 points.

Lower downside

BAC

BAC on Risk Resilience, by 45 points.

Analyst upside

BAC

BAC on implied upside to the consensus price target.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureBACNVAXNote
Implied upside to target+24.1%-6.2%BAC has more room
Target dispersion+25.3%0%Lower is tighter analyst agreement
ConsensusBuyHoldContext, not a primary driver
Analysts covering259Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

How each independent group of evidence reads the pair.

Evidence groupFavorsReading
AIQ ScoreNot coveredNot covered
FundamentalsNVAXon balancerevenue growth -3.3% vs 20.5%; EPS growth -23.8% vs 40.6%; TTM ROE 2.3% vs 14.5%; gross margin 60.4% vs 77.3%; operating margin 22.4% vs -19.6% — NVAX takes 4 of 5 decided legs, not all of them
ValuationNot coveredNot covered
TechnicalsBACPrice vs 50-day -5.6% vs -19.1%; vs 200-day -7% vs -8.7%
Risk ResilienceBACRisk Resilience 83 vs 38
Analyst expectationsBACTarget upside 24.1% vs -6.2%

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • Only 0 of 4 covered evidence groups agree. (argues the conclusion is provisional)

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

BACConflicted

2 bullish / 2 bearish / 1 neutral, conflicted

Only BAC

  • Bollinger Band Squeeze — neutral, volatility, short horizon (4.5%)
  • Death Cross Active — bearish, trend, long horizon (1.45%)
  • Downtrend Structure Active — bearish, trend, long horizon
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
  • OBV Bullish Divergence — bullish, volume, medium horizon (-0.4%)
NVAXConflicted

2 bullish / 2 bearish / 2 neutral, conflicted

Only NVAX

  • Golden Cross Active — bullish, trend, long horizon (12.89%)
  • ADX Trend Strengthening — neutral, trend, medium horizon
  • ATR Expansion - Breakout Mode — neutral, volatility, short horizon (10.03%)
  • BB Lower Band Breach — bullish, volatility, short horizon
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • MACD Histogram Expanding Bearish — bearish, momentum, short horizon

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

BACNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.01%, AIQ 0 points).

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

NVAX leads on balance
MetricBACNVAX
Revenue growth (YoY)-3.3%20.5%
EPS growth (YoY)-23.8%40.6%
Gross margin60.4%77.3%
Operating margin22.4%-19.6%
Return on equity (TTM)2.3%14.5%
Debt to equity1.28-1.36

Performance

Split across windows
MetricBACNVAX
1 week (5 sessions)3.2%-20.9%
1 month (20 sessions)-0.4%-24.3%
3 months (63 sessions)-20.1%5.6%
6 months (126 sessions)2.5%-5.9%
Year to date-7.2%26.9%
1 year (252 sessions)-5.7%18.4%

Technicals

BAC has the stronger structure
MetricBACNVAX
RSI (14)45.937.6
ADX (14)27.224
Price vs 50-day-5.6%-19.1%
Price vs 200-day-7%-8.7%
Volatility (1M, annualized)24.8%97.1%

Risk

BAC is the more resilient
MetricBACNVAX
Beta0.792.12
Sharpe ratio-0.220.56
Sortino ratio-0.290.93
Max drawdown-23.7%-34.6%
Current drawdown-21.3%-33.5%
Annualized volatility22.4%73.6%
Value at risk (95%)-2.6%-6.1%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which has more analyst upside, BAC or NVAX?

Analyst price targets imply +24.1% upside for BAC and -6.2% for NVAX, so the Street currently favors BAC. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, BAC or NVAX?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, BAC or NVAX?

NVAX on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, BAC or NVAX?

NVAX on the Momentum factor, by 40 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, BAC or NVAX?

BAC is the more resilient of the two, so the other name carries the higher downside risk. BAC on Risk Resilience, by 45 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is BAC more profitable than NVAX?

The profitability evidence is mixed: gross margin 60.4% vs 77.3%; operating margin 22.4% vs -19.6%; ttm roe 2.3% vs 14.5%. BAC leads on one measure and NVAX on two measures, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

What do the current signals say about BAC and NVAX?

BAC: 2 bullish / 2 bearish / 1 neutral, conflicted. NVAX: 2 bullish / 2 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on BAC is Death Cross Active (bearish, long horizon). On NVAX it is Golden Cross Active (bullish, long horizon).

Compare BAC and NVAX with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.